Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07835581
PHASE3
Study of Tegoprubart Efficacy and Safety Compared With Tacrolimus in Kidney Transplantation
Sponsor: Eledon Pharmaceuticals
View on ClinicalTrials.gov
Summary
This study will evaluate the efficacy and safety of tegoprubart compared with tacrolimus in adult participants undergoing first kidney transplantation.
Official title: A Multicenter, Phase 3 Randomized, Active-Controlled, Open-Label Study to Evaluate the Efficacy and Safety of Tegoprubart Compared With Tacrolimus in Adult Participants Undergoing De Novo Kidney Transplantation
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
620
Start Date
2026-10
Completion Date
2033-03
Last Updated
2026-09-30
Healthy Volunteers
No
Conditions
Interventions
DRUG
Tegoprubart
Tegoprubart administered via IV infusion
DRUG
Tacrolimus
Tacrolimus administered orally